Lab
E-Lab of Florida INC.
E-Lab of Florida INC. was paid $15K by Medicaid between Feb 2019 and Jun 2024, across 76 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 68% of everything it billed.
33Billing provider infoE-LAB OF FLORIDA INC.
HOLLYWOOD, FL 33024
HOLLYWOOD, FL 33024
33aNPI1427595354assigned 01/30/2017
33bProvider typeClinical Medical Laboratory
28Total paid$15K
24GClaims33,532
24DCodes billed76
24AFirst – last monthFeb 2019 – Jun 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#146 of 225
Median peer was paid$74K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 7,551 | $33.10 | |
| 2020 | 10,119 | $793.71 | |
| 2021 | 5,671 | $8K | |
| 2022 | 8,415 | $6K | |
| 2023 | 1,605 | $942.40 | |
| 2024incomplete | 171 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 68% | 2,482 | 1,159 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16% | 2,035 | 937 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.6% | 2,632 | 1,286 | $1K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 6.2% | 149 | 137 | $942.40 |
| 86769 | 1.1% | 997 | 440 | $168.54 | |
| 80053 | Comprehensive metabolic panel | <1% | 1,446 | 1,364 | $11.74 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,498 | 1,413 | $8.64 |
| 83735 | <1% | 57 | 43 | $7.44 | |
| 84100 | <1% | 45 | 34 | $5.28 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 1,249 | 1,183 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 1,258 | 1,182 | $0.00 |
| 85651 | 0% | 57 | 47 | $0.00 |
64 more codes
| 83550 | 0% | 44 | $0.00 | |
| 82607 | 0% | 374 | $0.00 | |
| 81279 | 0% | 168 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,168 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,649 | $0.00 |
| 81295 | 0% | 168 | $0.00 | |
| 81209 | 0% | 168 | $0.00 | |
| 84153 | 0% | 69 | $0.00 | |
| 81162 | 0% | 168 | $0.00 | |
| 81407 | 0% | 142 | $0.00 | |
| 81000 | 0% | 307 | $0.00 | |
| 81471 | 0% | 168 | $0.00 | |
| 81351 | 0% | 168 | $0.00 | |
| 81298 | 0% | 168 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 514 | $0.00 |
| 86141 | 0% | 63 | $0.00 | |
| 82746 | 0% | 53 | $0.00 | |
| 84436 | 0% | 63 | $0.00 | |
| 81400 | 0% | 284 | $0.00 | |
| 81223 | 0% | 168 | $0.00 | |
| 81320 | 0% | 181 | $0.00 | |
| 84480 | 0% | 47 | $0.00 | |
| 82728 | 0% | 26 | $0.00 | |
| 81161 | 0% | 44 | $0.00 | |
| 81440 | 0% | 42 | $0.00 | |
| 83880 | 0% | 43 | $0.00 | |
| 81218 | 0% | 168 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 3,095 | $0.00 |
| 81321 | 0% | 168 | $0.00 | |
| 81406 | 0% | 286 | $0.00 | |
| 84439 | 0% | 805 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,294 | $0.00 |
| 87634 | 0% | 629 | $0.00 | |
| 81408 | 0% | 286 | $0.00 | |
| 81401 | 0% | 286 | $0.00 | |
| 81490 | 0% | 168 | $0.00 | |
| 84550 | 0% | 771 | $0.00 | |
| 99001 | 0% | 65 | $0.00 | |
| 84481 | 0% | 667 | $0.00 | |
| 81311 | 0% | 168 | $0.00 | |
| 81404 | 0% | 286 | $0.00 | |
| 81405 | 0% | 286 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 1,063 | $0.00 |
| 87631 | 0% | 164 | $0.00 | |
| 81465 | 0% | 44 | $0.00 | |
| 81286 | 0% | 41 | $0.00 | |
| 80076 | 0% | 34 | $0.00 | |
| 82247 | 0% | 41 | $0.00 | |
| 81249 | 0% | 168 | $0.00 | |
| 81292 | 0% | 168 | $0.00 | |
| 81238 | 0% | 168 | $0.00 | |
| 81419 | 0% | 16 | $0.00 | |
| 81443 | 0% | 58 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 515 | $0.00 |
| 83970 | 0% | 50 | $0.00 | |
| 81403 | 0% | 142 | $0.00 | |
| 83540 | 0% | 145 | $0.00 | |
| 81334 | 0% | 168 | $0.00 | |
| 81307 | 0% | 168 | $0.00 | |
| 81317 | 0% | 168 | $0.00 | |
| 87799 | 0% | 319 | $0.00 | |
| 81460 | 0% | 42 | $0.00 | |
| 81192 | 0% | 42 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAMRA, AMIT (PRESIDENT)